Trials / Conditions / Mucinous Adenocarcinoma
Mucinous Adenocarcinoma
6 registered clinical trials studyying Mucinous Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant T NCT06182644 | Guangdong Provincial People's Hospital | N/A |
| Active Not Recruiting | METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin NCT05504252 | University Hospital, Akershus | Phase 2 |
| Unknown | BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei NCT03976973 | Mucpharm Pty Ltd | Phase 2 |
| Completed | Phase I Trial HIPEC With Nal-irinotecan NCT04088786 | Stony Brook University | Phase 1 |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Pa NCT00565851 | National Cancer Institute (NCI) | Phase 3 |